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Abstract
Background: Traditional harvesting of the internal thoracic artery (ITA) for use as a conduit in
coronary bypass surgery involves the dissection of a rim of tissue surrounding the artery on either
side. Recent studies, primarily observational, have suggested that skeletonization of the ITA can
improve conduit flow, increase length, and reduce the risk of deep sternal infection in high risk
patients. Furthermore, skeletonization of the ITA can potentially preserve intercostal nerves and
reduce post-operative pain and dysesthesias associated with ITA harvesting. In order to assess the
effects of ITA skeletonization, we report a prospective, randomized, within-patient study design
that shares many features of a cross-over study.
Methods: Patients undergoing bilateral internal thoracic artery harvest will be randomized to
having one side skeletonized and the other harvested in a non-skeletonized manner. Outcome
measures include ITA flow and length measured intra-operatively, post-operative pain and
dysesthesia, evaluated at discharge, four weeks, and three months post-operatively, and sternal
perfusion assessed using single photon emission computed tomography. Harvest times as well as
safety endpoints of ITA injury will be recorded.
Discussion: This study design, using within-patient comparisons and paired analyses, minimizes the
variability of the outcome measures, which is seldom possible in the evaluation of surgical
techniques, with minimal chance of carryover effects that can hamper the interpretation of
traditional cross-over studies. This study will provide a valid evaluation of clinically relevant effects
of internal thoracic artery skeletonization in improving outcomes following coronary artery bypass
surgery.
Introduction
Coronary artery bypass surgery (CABG) remains the gold
standard for the treatment of multi-vessel and left main
coronary disease[1]. The use of the internal thoracic arter-
ies (ITAs) as bypass conduits has been associated with
improved long-term outcome following CABG[2,3].
Despite these long-term benefits, there are certain charac-
teristics of the ITAs that limit their use in particular set-
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vasospasm and hypoperfusion in the early post-operative
period, particularly in the presence of vasoactive medica-
tions[4,5]. Harvest of the ITAs is associated with impair-
ment in sternal perfusion[6] and increased deep sternal
wound infections[7], particularly in diabetic patients. The
The intra-operative protocol involves measurement of ITA length (in-situ) as well as intra-operative flow measurements on four occ sionsFigure 1






Harvest ITA # 1
up to bifurcation
Measure In-situ Doppler
flow in ITA # 1
Measure Length
of ITA # 1
Harvest ITA # 2
up to bifurcation
Measure Length
of ITA # 2
Measure In-situ Doppler
flow in ITA # 2
Divide both ITAs at bifurcation and
measure direct flow in both ITAs
Coronary anastomoses
Measure post-anastomotic
Doppler flow in both ITAs
Heparin
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harvest has been associated with increased and persistent
post-operative pain [8-10].
The traditional ITA harvesting technique involves the dis-
section of a rim of tissue (1 – 2 cm) around the ITA. Skel-
etonization of the ITA has been proposed as a solution to
many of the problems associated with ITA harvesting. The
skeletonization procedure, first described by Keeley et al
in 1987[11], involves the harvest of only the ITA without
any surrounding tissue. This technique requires meticu-
lous dissection and carries the theoretical risk of increased
arterial injury. However, studies to date have not demon-
strated any differences in microscopic injury or vascular
function when compared to non-skeletonized
ITAs[12,13]. Numerous benefits of skeletonized ITA har-
vest have been proposed including increased flow[14] and
length[12], as well as a decreased sternal infection
rates[15], and reduced pain[16]. However, these asser-
tions are supported primarily by non-randomized, obser-
vational studies. It is not surprising, therefore, that there is
significant variation among surgeons as to the harvesting
technique employed.
In order to evaluate the differences in skeletonized versus
non-skeletonized ITA harvest, we propose the use of a
paired study design to evaluate within-patient differences




This study has been approved by the Institutional Review
Board of the University of Ottawa Heart Institute. All
patients undergoing isolated, non-emergent coronary
artery bypass surgery using bilateral internal thoracic
artery harvest by two surgeons will be screened for eligibil-
ity for this study. Exclusion criteria include known subcla-
vian artery stenosis, non-fluency in English or French, and
inability to complete follow-up visits. Of note, insulin-
dependent diabetes, systemic steroid use, and morbid
obesity remain relative contra-indications for bilateral
non-skeletonized internal thoracic artery use at our insti-
tution.
Study design, randomization, and blinding
This is a prospective, randomized study in which each
patient receives both study interventions i.e. a skele-
tonized ITA and a non-skeletonized ITA. Patients are ran-
domly allocated to receive a skeletonized ITA first
followed by a non-skeletonized harvest or vice versa i.e.
the order of treatments is randomly assigned. In addition,
the randomization scheme is stratified by the side to
which the intervention is applied in order to ensure equiv-
alent numbers of left and right sided ITAs that are skele-
tonized. Randomization will be performed intra-
operatively by opening a sealed, opaque envelope at the
time of sternotomy which contains computer-generated
random sequences assigned to each enrolled patient.
Patients will remain unaware of the treatment assignment
throughout the course of the study. Assessment of the out-
come measures will be performed by individuals blinded
to the treatment assignment whenever possible. Because
of the nature of certain endpoints, requiring visual feed-
back, evaluation of ITA length and flow will be performed
intra-operatively by individuals performing the ITA har-
vest who will be aware of the treatment assignment.
Outcome measures
The conduct of the intra-operative procedures as well as
the intra-operative outcomes is displayed in figure 1.
Conduit length
The length of the harvested ITA will be measured in-situ
(i.e. with the proximal and distal ends attached) from the
first rib to ITA bifurcation in a standardized fashion. After
the conduit has been fully dissected along its entire length
and prior to division of its distal end, the midportion will
be encircled by a length of sterile silk suture. Uniform ten-
sion will be applied to the two ends of the suture. A sepa-
rate silk suture will then be used follow the course of the
ITA to measure its length from the first rib to the ITA bifur-
cation. Separate sutures will be used for the left and right
sides and labeled in order to avoid misclassification.
Conduit flow
ITA flow will be measured on four separate occasions. The
first time point will be immediately following each indi-
vidual ITA harvest with the vessel in-situ, using a Doppler
flow meter (Transonics Inc., Binghamton, NY, USA). The
flow probe will be placed at a point approximately half-
way between the first rib and the ITA bifurcation. The size
of the probe will be chosen by the surgeon to best fit the
conduit and the same probe will be used for both ITAs in
order to minimize variability and measurement error. The
second measurement will be performed after both ITAs
have been harvested, are ready for distal division and sys-
temic heparin has been administered. Direct blood flow
from each ITA will be measured upon division by measur-
ing the amount of blood filling a calibrated cup over 15
seconds. The ITAs will then be treated with a vasodilator,
papaverine, applied topically, in order to eliminate any
vasospasm that may occur due to the handling as well as
mechanical or thermal trauma to the vessel. The third flow
measurement will be performed after a 5–10 minute treat-
ment with papaverine (equal duration of treatment for
both ITAs) using the direct flow technique described
above. The patient will then undergo coronary artery
bypass grafting and the final flow measurement will bePage 3 of 8
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using the Doppler flow probe.
The amount of flow within a vessel is a function of the sys-
temic blood pressure and the resistance offered by the ves-
sel. In addition, errors in measurement exist with all
measuring devices including the transonic Doppler flow
probe. Post-anastomotic Doppler flows are further
dependent on the size of the outflow vessel, the degree of
distal disease and the size and vasoreactive characteristics
of the distal myocardial bed that is supplied. Recognizing
these potential sources of inaccuracies, pre-anastomotic
This diagram depicts the anterior chest wall grid to be used for mapping of sensory deficitsFigure 2
This diagram depicts the anterior chest wall grid to be used for mapping of sensory deficits. Separate grids will be used for the 
mapping of defects in light touch, pin-prick, and temperature by a blinded observer and areas of anesthesia and hyperesthesia 
will be mapped using different symbols.Page 4 of 8
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both ITAs at approximately the same time will be used as
the primary outcome measure.
Chest wall pain and dysesthesia
Assessments of chest wall pain and dysesthesia will be per-
formed by a blinded observer. A questionnaire, designed
to assess differences in pain between the left and right
sides, will be administered to patients, and the degree of
pain will be quantified using a 100 mm Visual Analog
Scale (VAS), which has been used in numerous disciplines
to objectively quantify pain. Patients will also be ques-
tioned about the quality and the impact of post-operative
pain on their daily activities as well as the need for analge-
sic medication. However, only the VAS quantification of
pain will be side-specific.
There is a paucity of data on the optimal methodology for
assessing and quantifying post-operative dysesthesia of
the chest wall following ITA harvest. In consultation with
a pain specialist, we have developed a methodology for
the detailed assessment of sensory deficits of the anterior
chest wall. A sensory examination will be conducted by a
blinded observer employing three different sensory
modalities. Deficits in light touch, pinprick sensation, and
temperature will be mapped out on a grid (Figure 2) by
systematically testing the entire anterior chest wall from
the clavicle, superiorly, to the inferior edge of the midline
skin incision. These assessments of pain and dysesthesia
will be conducted upon discharge (4 – 6 days post-opera-
tively), at 4 weeks, and at 3 months post-operatively.
Sternal ischemia
A subgroup of patients (n = 15) will be randomly chosen
to undergo Single Photon Emission Computed Tomogra-
phy (SPECT) to assess sternal vascularity. Each study
involves complete tomographic imaging of the sternum
pre and post operatively (between post-operative days 3
and 5). The scan involves the use of 99mTc labeled methyl-
ene diphosphonate, and the results of SPECT imaging will
be analyzed as previously using a previously described
protocol [6,17], adapted to a paired side to side compari-
son. The results will be reported as counts/pixel.
Safety endpoints and other data collection
In addition to the outcome measures described, several
prospectively defined safety endpoints will be monitored.
These include ITA harvest time, gross ITA injury, sternal
fractures, chest tube drainage, need for re-operation for
bleeding, as well as superficial or deep sternal wound
infections. Information on baseline characteristics, intra-
operative variables and post-operative outcomes will also
be collected prospectively.
Statistical analysis and sample size calculations
The patient characteristics will be described using means
± SEM or medians (interquartile range) for normally dis-
tributed and skewed data as appropriate. Analysis of all
endpoints will be conducted using paired analysis. Con-
tinuous variables will be analyzed using 3-way ANOVA,
adjusting for stratification and time period variables. Dif-
ferences in conduit flow (ml/min), length (cm), sternal
perfusion (# pixel counts/cm2), chest wall pain (VAS
score), and area of chest wall dysesthesia (cm2) will be
analyzed using these methods. In addition, chest wall
pain and chest wall dysesthesia will also be dichotomized
and analyzed as binary endpoints using McNemar's test.
All statistical analyses will be conducted using SAS version
9.1 (SAS Institute, Cary, NC, USA).
For the purpose of sample size calculations, change in ITA
flow has been chosen as the primary outcome measure.
The reason for this choice is that a) this is a clinically
important early endpoint affected by harvesting tech-
nique, b) there is some preliminary data available from
observational studies evaluating ITA flow, and c) there is
a lack of preliminary data regarding other endpoints like
chest wall pain and dysesthesia to use for a sample size
calculation.
The sample size for this study will be 45 patients i.e. 45
pairs of ITAs. Using direct ITA flow at the second measure-
ment, prior to papaverine application, this study will be
powered to detect an absolute difference as low as 8 ml/
min between the skeletonized and non-skeletonized ITA
flows (30% increase in flow) with the assumption of a
mean flow of 26.4 ml/min in the non-skeletonized
group[14], at a two-sided alpha level of 0.05 and 90%
power. Since the estimate for the standard deviation of the
difference between paired samples is not known, the
standard deviation between unpaired samples of 16.1 was
used to calculate sample size[14]. Since the standard devi-
ation of the difference between paired samples is expected
to be less that this value, this likely overestimates the
required sample size. There is no anticipated loss to fol-
low-up with respect to the intra-operative ITA flow end-
point.
Discussion
Although the routine use of the internal thoracic arteries
is well established among cardiac surgeons, there is con-
siderable debate regarding the optimal harvesting tech-
nique for this conduit. In this paper, we describe the
rationale and study protocol, utilizing a paired study
design for the evaluation of skeletonized versus non-skel-
etonized harvest of the internal thoracic artery. The pri-
mary outcome measure for this study is intra-operative
ITA flow. Additional outcome measures include ITA
length, sternal perfusion, and post-operative pain andPage 5 of 8
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ment of multiple clinically relevant endpoints using an
efficient study design with within-patient comparisons.
Limitations of ITA use
The use of ITAs as bypass conduits has been demonstrated
to improve clinical outcomes following coronary artery
bypass surgery. However, there are several potential rea-
sons that limit the utilization of the ITA. First, the pre-dis-
position of the ITAs to post-operative vasospasm and
hypoperfusion can potentially be amplified in the pres-
ence of vasoactive medications and therefore, there is
some reluctance to using these conduits in patients under-
going emergency surgery as well as those with poor left
ventricular function. Catastrophic consequences of ITA
hypoperfusion, including death and cardiac transplanta-
tion, have been reported[4]. Second, there is a concern
that ITA harvest may compromise sternal healing. Clinical
studies have established the association between bilateral
ITA harvest and sternal wound infection, particularly in
diabetic patients[18]. Post-operative sternal infection and
mediastinitis have severe consequences including
increased mortality, prolonged intensive care unit and in-
hospital stay, and increased economic burden[7]. The
third factor relates to the length of usable conduit availa-
ble. The distal, post-bifurcation ITA is more prone to
vasospasm and its use has been linked to early graft occlu-
sion[5]. Although sequential arterial grafting is a strategy
that successfully reduces the amount of conduit needed,
one of the limitations to multi-vessel arterial grafting is
the length of available conduit[19]. Finally, due to the
close proximity of the ITA to cutaneous nerves of the chest
wall, its harvest by traditional techniques has been associ-
ated with significant persistent pain and sensory chest
wall changes, also termed the 'internal thoracic artery syn-
drome'[9]. Various studies have reproduced the finding of
increased post-operative pain in patients undergoing ITA
harvest versus sternotomy alone[8,10].
Proposed benefits of skeletonization
The traditional technique for ITA harvest involves a wide
dissection of tissue around the artery (approximately 1 to
2 cm) so as to include the internal thoracic vein and sur-
rounding muscle, fat, pleura and connective tissue as part
of the ITA pedicle. On the other hand, skeletonization,
which involves the harvest of only the artery, has been
reported to result in increased ITA length[12], larger lumi-
nal diameter[14], and higher ITA flows[20,21]. These
assertions are supported primarily by non-randomized,
observational studies, which are prone to bias as well as
affected by unmeasured confounders that differ between
patients e.g. patient size, gender, use of vasoactive medica-
tion, and hemodynamic status. One clinical study has also
suggested increased preservation of the sternal blood sup-
ply with single skeletonized ITA harvest[17]. Whether this
reduction in sternal ischemia leads to a decreased rate of
sternal wound infection is unknown. There is a suggestion
from observational studies that the incidence of sternal
complications in patients undergoing bilateral skele-
tonized ITA harvest is lower than the currently reported
rates for conventional bilateral ITA harvesting[15,22].
Only one observational study to date has examined early
post-operative pain with the finding of increased pain in
the non-skeletonized group[16]. Thus, there is a lack of
conclusive data on the proposed benefits of ITA skele-
tonization.
Paired, within-patient studies in surgery
The vast majority of randomized clinical trials utilize a
parallel study design to assess treatment differences
between groups. The paired study design is efficient
because it eliminates the effects of between-patient varia-
bility and therefore, significantly reduces the number of
patients required to detect a difference in the primary end-
point. This design shares many features of cross-over stud-
ies, which are often used to assess effects of medications
(e.g. blood pressure lowering medications) that are rela-
tively short acting and being used to treat a disease that is
relatively stable over time (e.g. hypertension). In cross-
over studies, all patients receive both treatments, and the
order in which treatments are administered is randomly
assigned. The major concerns with this study design are a)
carry over effects i.e. persistence of the effects of the first
treatment while the second treatment is being adminis-
tered, and b) changes in the disease state over the treat-
ment periods. The addition of a washout period between
treatments, when no treatment is administered, helps to
allay some of this concern[23]. In addition to the two
period cross-over design, more complicated cross-over
designs that can evaluate multiple treatments have also
been proposed[24].
Evaluation of surgical interventions is rarely amenable to
a cross-over design. However, occasionally the presence of
anatomic symmetry within a patient allows for a within-
patient comparison. One of the earliest applications of
this type of design in a surgical setting was the use of laser
photocoagulation in the eyes of diabetic patients using
the untreated eye as controls[25]. Our study design shares
a number of features of a cross-over study in that each
patient receives both treatments, the order in which treat-
ments are administered is randomized, and the outcomes
are assessed according to treatment assignment in a side-
specific manner. Although it provides an efficient study
design, an important implicit assumption of this design is
that the organs that receive the intervention are the same
i.e. in this case, that the left and right ITAs are the same,
both at the pre-treatment stage and with respect to their
response to treatment. Although this assumption seems
intuitively reasonable, there are certain anatomic differ-Page 6 of 8
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may question this assumption and this is a limitation of
this study design. To address this issue, the randomization
scheme will stratify according to side (left versus right) to
ensure equivalent numbers in both groups.
Another limitation is the inability to assess the effects of
skeletonization on sternal wound infections and other
endpoints that are not side-specific. Nevertheless, this
design allows for the control of various systemic factors
that are identical between the two ITAs. These factors
include patient size, the presence of diabetes, hyperten-
sion, and other cardiovascular risk factors, the systemic
consequences of surgical trauma, systemic endogenous
release or exogenous administration of vasoactive sub-
stances, and particularly important in our case, the subjec-
tive pain experience of each individual in response to
surgery. A unique feature of this type of paired study is
that the treatments are administered at roughly the same
time and therefore, period effects are not expected to play
a major role in confounding treatment related differences.
Summary
Skeletonization of the internal thoracic artery is a new sur-
gical technique that can potentially improve the quality of
the ITA as a bypass conduit as well as reduce post-opera-
tive morbidity. Although advantages of this technique
have been suggested in observational studies, definitive
data supporting its benefits is lacking. As such, there is sig-
nificant variation between surgeons in the harvesting
technique employed. As cardiac surgeons strive to
enhance the efficacy and minimize the morbidity associ-
ated with surgical interventions, this study will provide a
valid evaluation of clinically relevant effects of internal
thoracic artery skeletonization in improving outcomes
following coronary artery bypass surgery.
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